2-152607358-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_052905.4(FMNL2):c.896G>A(p.Arg299His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,613,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 11/19 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R299C) has been classified as Uncertain significance.
Frequency
Consequence
NM_052905.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FMNL2 | NM_052905.4 | c.896G>A | p.Arg299His | missense_variant | 10/26 | ENST00000288670.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FMNL2 | ENST00000288670.14 | c.896G>A | p.Arg299His | missense_variant | 10/26 | 1 | NM_052905.4 | P1 | |
FMNL2 | ENST00000475377.3 | c.896G>A | p.Arg299His | missense_variant | 10/28 | 5 | |||
FMNL2 | ENST00000492942.1 | n.458G>A | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152064Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000482 AC: 12AN: 248786Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134950
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461314Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726900
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152182Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74390
ClinVar
Submissions by phenotype
FMNL2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 25, 2023 | The FMNL2 c.896G>A variant is predicted to result in the amino acid substitution p.Arg299His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.037% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-153463872-G-A), which may be too common to be casuative of disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.896G>A (p.R299H) alteration is located in exon 10 (coding exon 10) of the FMNL2 gene. This alteration results from a G to A substitution at nucleotide position 896, causing the arginine (R) at amino acid position 299 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at